Additionally, the study shows young women are less likely to receive guideline-based therapies. In other words, less women are receiving aspirin, beta blockers, statins, stent use, and referral for bypass in hospitals. Dr. Khandewal says possible reasons for disparities could be because women often experience more side effects, so they’re reluctant to take these therapies. Another reason could be that women are a decade older when they present these heart problems. Finally, prescribers may be biased and not appreciate the true risk a female patient is facing.